Alto Neuroscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ANRO

Core Points - A class action lawsuit has been filed against Alto Neuroscience, Inc. for violations of federal securities laws [1][2] - The lawsuit claims that Alto made false and misleading statements regarding the effectiveness of its treatment ALTO-100 for major depressive disorder [2] - The class period for the lawsuit is from February 2, 2024, the date of Alto's IPO, to October 22, 2024 [2] Company Details - Shareholders who purchased shares during the class period are encouraged to contact DJS Law Group for potential lead plaintiff appointments [1][3] - The deadline for shareholders to register for participation in the lawsuit is September 19, 2025 [2] - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and alternative asset managers [4]